Ulcerative Colitis Chronic Mild Clinical Trial
Official title:
A Single-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Trial of Nicotinamide Mononucleotide in the Treatment of Mild Ulcerative Colitis
The goal of this clinical trial is to compare the safety and efficacy of nicotinamide mononucleotide (NMN) and placebo in patients with mild ulcerative colitis (UC). The main question it aims to answer is Whether NMN can alleviate the intestinal pathology of UC patients, so as to play a role in UC treatment or adjuvant therapy. Participants will be randomized into two groups, an NMN group or a placebo group. Patients in the NMN group were treated with NMN intervention for 8 weeks. The placebo group received a placebo intervention for 8 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04102852 -
Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT05538026 -
Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
|
N/A | |
| Recruiting |
NCT03408847 -
Monocultivar Coratina Extra Virgin Olive Oil in UC Patients
|
N/A | |
| Recruiting |
NCT05507931 -
Broccoli Sprouts for Mild Ulcerative Colitis
|
N/A | |
| Recruiting |
NCT03917095 -
The Safety and Efficacy of TET Enema in the Treatment of UC
|
N/A | |
| Terminated |
NCT03923478 -
ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
|
Phase 1 | |
| Recruiting |
NCT05666960 -
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
|
Phase 1 | |
| Recruiting |
NCT05194007 -
Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05791487 -
Combination of Diet and Oral Budesonide for Ulcerative Colitis
|
N/A | |
| Recruiting |
NCT03716388 -
Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
|
Phase 3 |